B) In situ determination of kahweol effects on HT - 1080 gelatinases, as determined by gelatin zymography with the presence of
kahweol in the incubation substrate buffer.
The minimal inhibitory concentration for
kahweol in this assay of «tubule - like» structures formation on Matrigel was 25 µM, in the range of concentrations at which other known antiangiogenic compounds produce this kind of effect [13], [27].
Not exact matches
Furthermore, a clear dose - response inhibition of microvessel formation was observed and quantified
in treatments with
kahweol.
In contrast, Video S2 shows that larvae treated with 50 µM
kahweol for 24 h exhibited no blood flow along intersegmental vessels.
A) Gelatin zymography of MMP - 2
in conditioned media of HUVEC after treatment with different
kahweol concentrations.
To get new, additional insights on the features of
kahweol as an anti-angiogenic compound, we carried out a complete set of
in vitro assays previously used by us to characterize the anti-angiogenic effects of other compounds from natural sources, including aeroplysinin - 1, homocysteine, ursolic acid, puupehenone, hypericin, hyperforin and aloe - emodin, among others [11], [12], [13], [19], [20], [21].
In the CAM assay, the inhibitory doses exhibited by kahweol are similar to those of other anti-angiogenic compounds found by us to inhibit angiogenesis in the CAM assay [10], [19], and much lower than those of other anti-angiogenic compounds [21
In the CAM assay, the inhibitory doses exhibited by
kahweol are similar to those of other anti-angiogenic compounds found by us to inhibit angiogenesis
in the CAM assay [10], [19], and much lower than those of other anti-angiogenic compounds [21
in the CAM assay [10], [19], and much lower than those of other anti-angiogenic compounds [21].
The global morphological features (including centrifugal growth of the peripheral vessels - relative to the position of the disc -, avoiding the treated area, with an overall decrease
in the vascular density) elicited by
kahweol treatment are also
in agreement with those previously observed for other anti-angiogenic compounds.
Altogether, our results demonstrate that
kahweol is a potent anti-angiogenic compound both
in vitro and
in vivo, targeting some key steps shared with tumor progression, key molecules involved
in ECM remodeling (MMP - 2 and uPA), and key molecules involved
in inflammation (COX - 2 and MCP - 1).
In all these in vitro assays, kahweol treatments were carried out under conditions (kahweol concentration and duration of treatment) that did produce no cytotoxic effect on cell
In all these
in vitro assays, kahweol treatments were carried out under conditions (kahweol concentration and duration of treatment) that did produce no cytotoxic effect on cell
in vitro assays,
kahweol treatments were carried out under conditions (
kahweol concentration and duration of treatment) that did produce no cytotoxic effect on cells.
On the other hand, the present research work shows a confirmatory evidence of the potential of
kahweol to inhibit
in vivo angiogenesis, by using another completely independent model system, namely, that of genetically modified zebrafish.
Taken together, our data indicate that, indeed,
kahweol behaves as an anti-inflammatory and anti-angiogenic compound with potential use
in antitumoral therapies.
Figure 8 (C) shows that
kahweol - treatment induces a dose - dependent decrease
in the levels of urokinase
in HUVEC conditioned media, with an almost complete inhibition at 50 µM
kahweol.
Different
in vitro assays were carried out
in order to test the specific effects of
kahweol treatment on several key steps of the angiogenic process
in both endothelial and tumor cells.
The CAM and zebrafish
in vivo assays and the ex vivo mouse aortic ring assay clearly identify
kahweol as a new anti-angiogenic compound, but gives no information on which specific steps of angiogenesis are targeted by this compound.
Figure 2 (middle line) shows that 50 nmol
kahweol induced apoptosis
in a small percentage of cells but this effect did not seem to be endothelial cell specific, since only few apoptotic nuclei corresponded to endothelial cells.
One of these is
kahweol (Figure 1), an antioxidant diterpene that remains
in unfiltered coffee beverages, such as Turkish and Scandinavian coffee [3].
Video images of blood flow thru intersegmental vessels were taken on the caudal region next to vitellus
in 48 h larvae after 24 h of treatment
in the absence (control, Video S1) or presence (Video S2) of 50 µM
kahweol.
We also demonstrate the inhibitory effect of
kahweol on the endothelial cell potential to remodel extracellular matrix by targeting two key molecules involved
in the process, MMP - 2 and uPA.
Figure 9 (A and B) shows that
kahweol inhibits
in a dose dependent manner the expression of COX - 2 protein by HUVEC.
C) Quantification of the amount of MCP - 1 secreted by HUVEC after a 24 h treatment
in the presence of different concentrations of
kahweol.
Data obtained on the effects of
kahweol on endothelial cell invasion (as determined by a continuous fluorescent assay) clearly show that
kahweol induces an anti-invasive effect
in HUVEC
in a dose - dependent manner (Figure 7).
Therefore,
kahweol - treatment has another key target
in this essential step of the angiogenesis process.
The gelatinolytic assays were carried out
in two different ways to obtain complementary information: firstly, cells were treated or not with the test compound and samples from these were submitted to gelatinase zymography to detect the effects of the
kahweol treatment on the expression of gelatinase activities; secondly,
in some experiments, samples from control, untreated HT - 1080 fibrosarcoma cells were submitted to zymography and, after electrophoresis, different concentrations of
kahweol were added to the substrate buffer to determine the potential direct effect of
kahweol on gelatinase activity.
Subconfluent HUVEC cultures were stimulated with PMA (50 ng / mL) for 4 h
in the absence (controls) or presence of different concentrations of
kahweol.
A) Negative of photographs (x20) of aortic rings (lateral view) after 10 days of incubation
in a 3D collagen gel overlayed with complete medium
in the presence of 20 mg / mL VEGF, 0.05 % DMSO (the vehicle taken as a control), or
kahweol at 1, 5 and 25 µM (K1, K5, K25, respectively).
Although 50 nmol of
kahweol per CAM was required to observe
in vivo inhibition of angiogenesis
in 100 % of treated eggs, as little as 10 nmol of
kahweol was enough to induce clear inhibition of angiogenesis
in 25 % of the tested eggs
in the CAM assay.
We show for the first time that
kahweol is an anti-angiogenic compound with inhibitory effects
in two
in vivo and one ex vivo angiogenesis models, with effects on specific steps of the angiogenic process: endothelial cell proliferation, migration, invasion and tube formation on Matrigel.
Our results
in the zymographic assays for gelatinase and urokinase activities clearly showed that,
in fact,
kahweol was able to inhibit the expression of both MMP - 2 and uPA, identifying them as two relevant molecular targets for
kahweol.
It has been shown previously that
kahweol exerts a suppressive effect on COX - 2 expression
in macrophages [38].
Diterpenes such as cafestol and
kahweol are both present
in the oil contained within the coffee bean, and these can increase your total cholesterol and LDL levels.
Medicinal compounds detected
in coffee include lignans, quinides, antioxidants, dipertenes like
kahweol and cafestol...
Research on the antioxidant activity of trigonelline, cafestol and
kahweol has been less extensively investigated
in humans.
Other compounds found
in coffee include phenol chlorogenic acid (an antioxidant), potassium, magnesium, niacin (vitamin B1),
kahweol, and cafestol.